Deutsche Bank
BDTX icon

Deutsche Bank’s Black Diamond Therapeutics BDTX Stock Holding History

Deutsche Bank’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,388
Closed -$34.7K – 3617
2025
Q1 		$34.7K Hold
22,388
– – ﹤0.01% 3432
2024
Q4 		$47.9K Hold
22,388
– – ﹤0.01% 3421
2024
Q3 		$97.4K Hold
22,388
– – ﹤0.01% 3227
2024
Q2 		$104K Buy
+22,388
New +$120K ﹤0.01% 3093
2022
Q4 		– Sell
-321,602
Closed -$544K – 4010
2022
Q3 		$544K Buy
+321,602
New +$992K ﹤0.01% 2322
2022
Q2 		– Sell
-12,363
Closed -$34K – 4134
2022
Q1 		$34K Sell
12,363
-1,462
-11% -$5.34K ﹤0.01% 3943
2021
Q4 		$74K Sell
13,825
-11,138
-45% -$77.8K ﹤0.01% 3826
2021
Q3 		$211K Sell
24,963
-91,882
-79% -$907K ﹤0.01% 3542
2021
Q2 		$1.42M Buy
116,845
+104,380
+837% +$2.06M ﹤0.01% 2538
2021
Q1 		$302K Sell
12,465
-1,095
-8% -$29.5K ﹤0.01% 3407
2020
Q4 		$435K Buy
13,560
+3,637
+37% +$119K ﹤0.01% 3000
2020
Q3 		$300K Sell
9,923
-5,747
-37% -$175K ﹤0.01% 2964
2020
Q2 		$661K Buy
15,670
+2,045
+15% +$75.3K ﹤0.01% 2481
2020
Q1 		$340K Buy
+13,625
New +$415K ﹤0.01% 2679

Other funds holding BDTX

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Deutsche Bank's BDTX Position: Q2 2025 in Review

Deutsche Bank sold out of Black Diamond Therapeutics (BDTX) in Q2 2025, closing a stake of 22,388 shares — an estimated $34.7K sold.

Deutsche Bank first reported a position in BDTX in Q1 2020 and held it in 14 quarters. The position peaked at $1.42M in Q2 2021. 94 funds tracked by Wall St. Rank hold BDTX as of Q2 2025.

  • Deutsche Bank reported no remaining Black Diamond Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 22,388 Black Diamond Therapeutics shares in Q2 2025, an estimated $34.7K.
  • Deutsche Bank first reported a position in Black Diamond Therapeutics in Q1 2020 and held it in 14 quarters.
  • Deutsche Bank's Black Diamond Therapeutics position peaked at $1.42M in Q2 2021.
  • 94 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.